Vitexin showed a trend toward reduction in hepatic tissue (Figure 4E ) while significantly decreasing renal UA content ( p < 0.05; Figure 4F ), comparable to those of benzbromarone.
← all excerpts
Antihyperuricemic Effect of Hawthorn Flavonoid Vitexin: LC-MS Analysis, Network Pharmacology, and In Vivo Verification of Molecular Mechanisms.
1
—
—